Want to create interactive content? It’s easy in Genially!

Get started free

Pregnancy & Lactation - landscape

Madeleine Kochis

Created on October 13, 2025

Start designing with a free template

Discover more than 1500 professional designs like these:

Urban Illustrated Presentation

Geographical Challenge: Drag to the map

Decisions and Behaviors in the Workplace

Tangram Game

Process Flow: Corporate Recruitment

Weekly Corporate Challenge

Wellbeing and Healthy Routines

Transcript

Drug Therapy in Pregnancy & Lactation
Self Assessment

Instructions

This self-assessment study guide has 2 questions, each written using learning objectives from your Principles of Drug Therapy in Pregnancy & Lactation lecture. Not all learning objectives are covered. Participation/scores are not monitored. FYI this program makes noise sometimes.

Symbols

A clipboard will bring up relevant patient information.

A lightbulb in the top right corner of a page indicates that the page contains answers or explanations.

Question 1

For each pair of drugs, select which is more likely to cross the placenta.

Question 1

MOLECULAR WEIGHT

SOLUBILITY

PROTEIN BINDING

CHARGE

Small (<500 Da) → more likely to cross placenta

Lipophilic → more likely to cross placenta

Non-ionized → more likely to cross placenta

Low protein binding → more likely to cross placenta

Use this side of the card to provide more information about a topic. Focus on one concept. Make learning and communication more efficient.

Use this side of the card to provide more information about a topic. Focus on one concept. Make learning and communication more efficient.

Use this side of the card to provide more information about a topic. Focus on one concept. Make learning and communication more efficient.

Use this side of the card to provide more information about a topic. Focus on one concept. Make learning and communication more efficient.

Large → less likely to cross placenta

Water-soluble → less likely to cross placenta

Highly protein-bound → less likely to cross placenta

Ionized → less likely to cross placenta

Title

Title

Title

Title

Write a brief description here

Write a brief description here

Write a brief description here

Write a brief description here

The next two pages contain subjective and objective information about a patient. Read the information then answer the two questions that follow. While answering questions, click the clipboard to review the patient information at any time.

Question 2

Subjective

Patient is a 30-year-old female presenting for her first prenatal appointment. Pharmacy consulted for medication review and recommendations. Patient believes last menstrual period was around 8 weeks ago. She and spouse are excited and nervous about pregnancy. Experiencing nausea which has significantly worsened over the last week or so, causing her to miss work twice. Lasts 2-4 hours every day. Vomited on two separate occasions. Also seeking advice about anxiety. Says she was prescribed fluoxetine as a teenager, which was effective, but has been managing well without medication for several years. Is feeling anxious about pregnancy and is worried about becoming overwhelmed.

Past medical history

  • Hypertension
  • Hypothyroidism
  • Generalized anxiety disorder

Medications

  • Lisinopril 40 mg once daily
  • Levothyroxine 137 mcg once daily

Question 2

Objective

Vital sign

Result

BP

HR

RR

Weight

Height

136/86 mmHg

84 bpm

16 bpm

84 kg

165 cm

BMI

30.9 kg/m2

Test

Result

Potassium

Creatinine

eGFR

Glucose

TSH

4.4 mmol/L

0.8 mg/dL

>90 mL/min/1.73 m2

85 mg/dL

5.5 mlU/L

Free T4

1.3 ng/dL

Reference

3.5 - 5.0

0.6 - 1.2

>60

70 - 100

0.4 - 4.5*

0.8 - 1.8

*TSH reference limit upper range during pregnancy is 2.5 mlU/L.

Question 2

Current medications - Lisinopril 40 mg once daily - Levothyroxine 137 mcg once daily

Question 2

Current medications - Lisinopril 40 mg once daily - Levothyroxine 137 mcg once daily

Question 2

Hypothyroidism

It is recommended to increase levothyroxine dose by 25% once pregnancy is confirmed. TSH should be checked every 4 to 6 weeks throughout pregnancy and dose should be titrated accordingly.

Hypertension

ACE inhibitors (lisinopril) and ARBs (losartan) are contraindicated during pregnancy. Labetalol and nifedipine are first line, and methyldopa is second line.

Nausea/vomitting

Patient seems to have moderate to severe nausea, for which vitamin B6 and/or antihistamines are first line. It wouldn’t hurt to recommend nonpharmacologic options such as ginger or acupuncture as well. Ondansetron is a 3rd line option and should not be recommended. Polyethylene glycol is a helpful option for constipation, but will not help the patient’s nausea/vomiting.

Anxiety

Since patient is not currently on medications for anxiety, behavioral therapy would be first line. However, if the benefits outweigh risks for this patient, starting an SSRI (besides paroxetine) would be appropriate.

THANK YOU!

Subjective 32-year-old female presenting for first prenatal visit Last menstrual period: ~8 weeks ago Nausea

  • Significantly worsened over last week or so
  • 2-4 hours every day
  • 2 vomiting episodes
Anxiety
  • Fluoxetine effective as teenager; has been managing well without medication for several years
  • Patient concerned about increasing anxiety with pregnancy news
PMH: hypertension, hypothyroidism, GAD

Objective (select information)Labs/vitals all from today

  • BP: 136/86 mmHg
  • Weight: 84 kg
  • BMI: 30.9 kg/m2
  • K: 4.4 mmol/L
  • SCr: 0.8 mg/dL
  • TSH: 5.5 mlU/L (H)
  • Free T4: 1.3 mg/dL

Subjective 32-year-old female presenting for first prenatal visit Last menstrual period: ~8 weeks ago Nausea

  • Significantly worsened over last week or so
  • 2-4 hours every day
  • 2 vomiting episodes
Anxiety
  • Fluoxetine effective as teenager; has been managing well without medication for several years
  • Patient concerned about increasing anxiety with pregnancy news
PMH: hypertension, hypothyroidism, GAD

Objective (select information)Labs/vitals all from today

  • BP: 136/86 mmHg
  • Weight: 84 kg
  • BMI: 30.9 kg/m2
  • K: 4.4 mmol/L
  • SCr: 0.8 mg/dL
  • TSH: 5.5 mlU/L (H)
  • Free T4: 1.3 mg/dL